# Measles Vaccine in HCW

> **NCT04357028** · PHASE3 · SUSPENDED · sponsor: **Kasr El Aini Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Measles-Mumps-Rubella Vaccine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04357028
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-07-13
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** Failure of subject recruitment
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04357028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04357028, "Measles Vaccine in HCW". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04357028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*